EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study

Cecilia Morel iD, Fiona M Walter, Pawandeep Virpal, Kirsten D Arendse iD, Garth Funston

British Journal of General Practice · 2026

DOI: 10.3399/bjgp.2025.0780 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of General Practice, 2026. Verfasst von Cecilia Morel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Practice Patterns, Physicians', Primary Health Care, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prescribing patterns in primary care could demonstrate early clinical features of cancer and windows of opportunity for timely investigation.

Aim

To analyse primary care prescription patterns before a pancreatic cancer diagnosis. Design and setting Retrospective cohort study using linked primary care and cancer registry data from patients diagnosed with pancreatic cancer in England between 2011 and 2018.

Method

Prescription records registered in the Clinical Practice Research Datalink were analysed in the 5 years prediagnosis. Eight categories of prescriptions that may be used to treat clinical features of pancreatic cancer were included (anti-emetics, anti-reflux medications, insulin, other hypoglycaemic agents, opioids, non-opioid analgesics, neuropathic analgesics, and non-steroidal anti-inflammatories). Poisson regression was used to estimate the inflection points for increased prescribing above baseline.

Results

Among 12 990 patients, 669 287 prescriptions were analysed. Insulin was the least common prescription (6.9% [ n = 892/12 990] of patients), anti-reflux the most common (52.6% [ n = 6833/12 990] of patients). Insulin prescribing increased 19 months prediagnosis (95% confidence interval [CI] = 14.2 to 23.8), rising earlier in female patients (25 months; 95% CI = 17.4 to 32.5) than male patients (11 months; 95% CI = 5.8 to 16.2). Prescriptions for other hypoglycaemic agents increased 13 months (95% CI = 7.7 to 18.5), anti-reflux and opioid analgesic prescribing 7 months (95% CI = 5.4 to 8.6 and 4.4 to 9.6, respectively), and anti-emetics and non-opioid analgesics 5 months (95% CI = 2.9 to 7.1 and 3.2 to 6.8, respectively) before diagnosis.

Conclusion

The early increase in insulin prescribing suggests tumour-induced type 3c diabetes, highlighting an opportunity for earlier diagnosis in a small proportion of patients. Opportunities for earlier diagnosis through investigation and referral also exist in patients prescribed anti-emetic, anti-reflux, and analgesic medications in primary care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPractice Patterns, Physicians'Primary Health CareDrug PrescriptionsHumansRetrospective StudiesFemaleMaleEnglandAgedHypoglycemic AgentsInsulinMiddle AgedAnalgesics, OpioidAntiemeticsAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

diabetes mellitusearly diagnosisinsulinpancreatic cancerprescriptionsprimary health care

Substanzen

Hypoglycemic AgentsInsulinAnalgesics, OpioidAntiemeticsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK g.funston@qmul.ac.uk.

ORCID-Profile: Cecilia Morel, Kirsten D Arendse

Zitieren

APA

Morel, C., Walter, F. M., Virpal, P., Arendse, K. D., & Funston, G. (2026). Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study. British Journal of General Practice. https://doi.org/10.3399/bjgp.2025.0780

Vancouver

Morel C, Walter FM, Virpal P, Arendse KD, Funston G. Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study. British Journal of General Practice. 2026. doi:10.3399/bjgp.2025.0780

BibTeX
@article{Morel2026,
  author = {Morel, Cecilia and Walter, Fiona M and Virpal, Pawandeep and Arendse, Kirsten D and Funston, Garth},
  title = {Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study},
  journal = {British Journal of General Practice},
  year = {2026},
  doi = {10.3399/bjgp.2025.0780}
}
Kostenlos starten →